Fenikso Limited (AQU:FNK)
London · Delayed Price · Currency is GBP · Price in GBX 1.800
0.00 (0.00%)
At close: Jul 30, 2025
CTI BioPharma Market Cap
Fenikso has a market cap or net worth of 8.44 million as of July 31, 2025. Its market cap has increased by 42.75% in one year.
Market Cap
8.44M
Enterprise Value
12.48M
Revenue
n/a
Ranking
n/a
PE Ratio
11.40
Stock Price
$1.80
Market Cap Chart
Since May 17, 2013, Fenikso's market cap has decreased from 71.28M to 8.44M, a decrease of -88.15%. That is a compound annual growth rate of -16.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2025 | 8.44M | 27.48% |
| Dec 31, 2024 | 6.62M | 73.39% |
| Dec 29, 2023 | 3.82M | -2.50% |
| Dec 1, 2022 | 3.92M | -58.27% |
| Dec 31, 2020 | 9.39M | -62.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 173.02B |
| HSBC Holdings | 168.02B |
| Shell | 158.49B |
| Unilever | 110.42B |
| British American Tobacco p.l.c. | 86.00B |
| Rolls-Royce Holdings | 83.88B |
| Rio Tinto Group | 79.46B |
| RELX PLC | 71.37B |